References

1. Ponsky LE, Crownover RL, Rosen MJ, et al. Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation. Urology 2003; 61:498-501.

2. Krawitt DR, Addonizio JC. Ultrasonic aspiration of prostate and bladder tumors and stones. Urology 1987; 30:579-742.

3. Papchristou DN, Bartens R. Resection of the liver with a water jet. Br J Surg 1982; 69:93-94.

4. Higashihara E. Mechanical energy in urology for non-lithiasis treatment. In: Marberger M, ed. Application of newer forms of therapeutic energy in urology. Oxford: Isis Medical, 1995:1-13.

5. Basting RF, D'akovic N, Widmann P. Use of water jet resection in organ-sparing kidney surgery. J Endourol 2000; 14:501-505.

6. Chopp RT, Shah BB, Adonizio JC. Use of ultrasonic surgical aspirator in renal surgery. Urology 1983; 22:157-159.

7. Hodgson WJ, Del Guercio LRM. Preliminary experience in liver surgery using the ultrasonic scalpel. Surgery 1984; 2:230-234.

8. Gill BS, MacFadyen BV Jr. Ultrasonic dissectors and minimally invasive surgery. Semin Laparosc Surg 1999; 6:229-234.

9. Schmidbauer S, Hallfeldt KK, Sitzmann G, Kantelhardt T, Trupka A. Experience with ultrasound scissors and blades (UltraCision) in open and laparoscopic liver resection. Ann Surg 2002; 235:27-30.

10. Lingeman JE, Mc Ateer JA, Kempson SA, et al. Bioeffects of extracorporeal shock-wave lithotripsy. Urol Clin North Am 1988; 15:507-514.

11. Coleman AJ, Saunders JE. A survey of the acoustic output of commercial extracorporeal shockwave lithotripsy. Ultrasound Med Biol 1989; 15:213-227.

12. Madersbacher S, Marberger M. Therapeutic applications of ultrasound in urology. In: Marberger M, ed. Application of newer forms of therapeutic energy in urology. Oxford: ISIS, 1995:115-136.

13. Crum LA. Cavitation microjets as a contributory mechanisms for renal calculi disintegration in shock-wave. J Urol 1988; 140:1587-1590.

14. Filipczynski L, Wojcik KS. The estimation of transient temperature elevation in lithotripsy and in ultrasonography. Ultrasound Med Biol 1991; 17:715-721.

15. Suhr D, Bruemmer F, Huelser DF. Cavitation generated free radicals during shock-wave exposure: investigators with cell-free solutions and suspended cells. Ultrasound Med Biol 1991; 17:761-768.

16. Morgan TR, Laudone VP, Heston WDW, et al. Free radical production by high energy shock waves—comparison with ionizing irradiation. J Urol 1988; 139:186-189.

17. Russo P, Stephenso RA, Mies C, et al. High energy shock waves suppress tumor growth in vitro and in vivo. J Urol 1986; 135:626-628.

18. Randazzo RF, Chaussy CG, Fuchs GJ, et al. The in vitro and in vivo effects of extracorporeal shockwave on malignant cells. Urol Res 1988; 16:413-426.

19. VanDongen JW, VanSteenbrugge GJ, Romijn JC, Schroeder FH. The cytocidal effect of high energy shock waves on human prostatic tumor cell lines. Eur J Cancer Clin Oncol 1989; 25:1173-1179.

20. Kohri K, Vemura T, Iguchi M, et al. Effect of high energy shock-waves on tumor cells. Urol Res 1990; 18:101-105.

21. Smits GAH, Oosterhof GON, Ruyter AE, et al. Cytotoxic effects of high energy shock-waves in different in vitro models: influence of the experimental set-up. J Urol 1991; 145:171-175.

22. Brummer F, Brenner J, Brauner T, et al. Effect of shock-waves on suspended and immobilized LI220 cells. Ultrasound Med Biol 1989; 15:229-239.

23. Gambihler S, Delius M, Brendel W. Biological effect of shock waves: cell disruption, vitality and proliferation of LI210 cells exposed to shock waves in vitro. Ultrasound Med Biol 1990; 16:587-594.

24. Prat F, Sibille A, Luccioni C, et al. Increased chemotoxicity to colon cancer cells by shock-wave induced cavitation. Gastroenterology 1994; 106:937-944.

25. Woerle K, Steinbach P, Hofstadter F. The combined effects of high-energy shock waves and cyto-static drugs or cytokines on human bladder cancer cells. Br J Cancer 1994; 69:58-65.

26. Gambihler S, Delius M. In vitro interaction of lithotripter shock-waves and cytotoxic drugs. Br J Cancer 1992; 66:69-73.

27. Maruyama M, Asano T, Nakagohri T, et al. Application of high energy shock waves to cancer treatment in combination with cisplatin and ATX-70. Anticancer Res 1999; 19:1989-1993.

28. Cornel EB, Oosterwijk E, Van de Streek JD, et al. High energy shock waves induced increase in the local concentration of systemically given TNF-alpha. J Urol 1994; 152:2164-2166.

29. Russo P, Mies C, Huryk R, et al. Histopathologic and ultrastructural correlations of tumor growth suppression by high energy shock-waves. J Urol 1987; 137:338-341.

30. Oosterhof GON, Smits GA, De Ruyter AE, Schalken JA, Debruyne FM. Effects of high-energy shock-waves combined with biological response modifiers in different human kidney cancer xenografts. Ultrasound Med Biol 1991; 17:391-399.

31. Hoshi S, Orikasa S, Kuwahara M, et al. High energy underwater shock wave treatment on implanted urinary bladder cancer in rabbits. J Urol 1991; 146:439-443.

32. Vallancien G, Chartier-Kastler E, Chopin D, Veillon B, Brisset JM, Andre-Bougaran J. Focused extracorporeal pyrotherapy: experimental results. Eur Urol 1991; 20:211-219.

33. Vallancien G, Harouni M, Veillon B, et al. Focused extracorporeal pyrotherapy: feasibility study in man. J Endourol 1992; 6:173-181.

34. Chartier-Kastler E, Chopin D, Vallancien G. The effects of focused extracorporeal pyrotherapy on a human bladder tumor line (647V). J Urol 1993; 149:643-647.

35. Vallancien G, Harouni M, Giullonneau B, Veillon B, Bougaran J. Ablation of superficial bladder tumors with focused extracorporal pyrotherapy. Urology 1996; 47:204-207.

36. Holmes RP, Yeaman LI, LI WJ, et al. The combined effects of shock waves and cisplatin on rat prostate tumors. J Urol 1990; 144:159-163.

37. Gamarra F, Naegele M, Lumper W, et al. Acute effect of shock waves on tumors assessed by magnetic resonance imaging. Possible role of blood flow reduction. Invest Radiol 1993; 28:611-618.

38. Fry FJ. Intense focused ultrasound in urology. Eur Urol 1993; 23(suppl 1):2-7.

39. Ter Haar GR, Robertson G. Tissue destruction with focused ultrasound in vivo. Eur Urol 1993; 23:8-11.

40. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995; 55:3346-3351.

41. Gelet A, Chapelon JY. Effects of high-intensity focused ultrasound on malignant cells and tissues. In: Marberger M, ed. Application of newer forms of therapeutic energy in urology. Oxford: ISIS, 1995:107-114.

42. Lacoste F, Schlosser J, Vallancien G. The benefit of electronic scanning in extracorporeal HIFU. In: Andrew MA, Crum LA, Vaezy S, eds. Proceedings, 2nd international symposium on therapeutic ultrasound. Seattle: University of Washington, 2003:314-322.

43. Kishi M, Mishima T, Itakura T. Experimental studies of effects of intense ultrasound on implantable murine glioma. In: Kazner E, deVlieger M, Muller HR, McCready VR, eds. Proceeding of 2nd European congress on ultrasonics medium. Amsterdam: Excerpta Medica, 1975:28-33.

44. Fry FJ, Johnson LK. Tumor irradiation with intense ultrasound. Ultrasound Med Biol 1978; 4:337-341.

45. Moore WE, Lopez RM, Matthews DE, et al. Evaluation of high intensity therapeutic ultrasound irradiation in the treatment of experimental hepatoma. J Pediatr Surg 1989; 24:30-33.

46. Chapelon JY, Margonari J, Vernier F, Gorry F, Eccochard R, Gelet A. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 1992; 52:6353-6357.

47. Goss SA, Fry FJ. The effect of high intensity ultrasonic irradiation on tumor growth. IEEE Trans Sonics Ultrason 1984; 31:491-496.

48. Yang R, Reilly CR, Rescoria FJ, et al. High-intensity focused ultrasound in the treatment of experimental liver cancer. Arch Surg 1991; 126:1002-1009.

49. Kaketa K, Wagai T, Mizuno S, et al. Medical application of intense ultrasound, III: destruction of malignant tumor by intense focused ultrasound. In: Annual report (1970) of the Medical Ultrasonics Research Center. Tokyo, Japan: Juntendo University School of Medicine, 1971:35-39.

50. Oosterhof GO, Cornel EB, Smith GA, Debruyne FM, Schalken JA. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 1997; 32:91-95.

51. Foster RS, Bihrle R, Sanghvi NT, et al. Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound. Eur Urol 1993; 23:330-336.

52. Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M. Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol 1993; 23(suppl 1):39-43.

53. Madersbacher S, Kratzik C, Susani M, Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994; 152:1956-1961.

54. Bihrle R, Foster RS, Sanghvi NT, Donohue JP, Hood PJ. High intensity focused ultrasound for the treatment of BPH: early U.S. clinical experience. J Urol 1994; 151:1271-1275.

55. Uchida T, Yokoyama E, Iwamura M, et al. High intensity focused ultrasound for benign prostatic hypertrophy. Int J Urol 1995; 2:181-185.

56. Sanghvi NT, Foster RS, Bihrle R, et al. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound 1999; 9:19-29.

57. Madersbacher S, Schatzl G, Djavan B, Stulnig T, Marberger M. Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol 2000; 37:687-694.

58. Gelet A, Chapelon JY, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996; 29:174-183.

59. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 1999; 161:156-162.

60. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing outcome. Eur Urol 2001; 40:124-129.

61. Kratzik C, Schatzl G, Lackner J, Marberger M. Transcutaneous high-intensity focused ultrasound can cure testicular cancer. Urology 2006; 67:1269-1273.

62. Thuroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 2003; 17:673-677.

63. Thuroff S, Chaussy C. The impact of the energy dose of transrectal high-intensity focused ultrasound for the treatment of prostatic cancer. J Urol 2004; 171(suppl 1):271.

64. Chauhan S, Lowe MJ, Davies BL. A multiple focused probe approach for high intensity focused ultrasound based surgery. Ultrasonics 2001; 39:33-44.

65. Sokka SD, Hynynen KH. The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array. Phys Med Biol 2000; 45:3373-3383.

66. Lizzi FL, Muratore R, Deng CX, et al. Radiation-force technique to monitor lesions during ultrasonic therapy Ultrasound Med 2003; 29:1593-1605.

67. Gelet A, Chapelon JY, Poissonnier L, et al. Local recurrence of prostate cancer after external beam radiotherapy early experience of salvage therapy using high-intensity foced ultrasonography. Urology 2004; 63:625-629.

68. Kramer G, Steiner GE, Gröbl M, et al. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T cells. Prostate 2004; 58:109-120.

69. Huber PE, Pfisterer R. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther 2000:7; 1516-1526.

70. Heidenreich A, Weissbach L, Hotl W, et al. Organ sparing surgery for malignant germ cell tumors. J Urol 2001; 166:2161-2165.

71. Madersbacher S, Kratzik C, Susani M, Pedevilla M, Marberger M. Transcutaneous high-intensity focused ultrasound and irradiation: an organ-preserving treatment of cancer in a solitary testis. Eur Urol 1998; 33:195-201.

72. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166:1611-1623.

73. Rendon RA, Stanietzky N, Panzarello T, et al. The natural history of small renal masses. J Urol 2000; 164:1143-1197.

74. Frank I, Blue ML, Cheville JC, et al. Solid renal tumors analysis of pathological features related to tumor size. J Urol 2003; 170:2217-2220.

75. Schachter LR, Bach AM, Snyder M, Kattan MW, Russo P. The impact of tumor location histological subtype of renal cortical tumors. J Urol 2004; 171:472.

76. Paterson RF, Barret E, Siqueria TM, et al. Laparoscopic partial kidney ablation with high intensity focused ultrasound. J Urol 2003; 169:347-351.

77. Adams JB, Moore RG, Anderson JA, et al. High intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol 1996; 10:71-75.

78. Chapelon JY, Margonari J, Theillere Y, et al. Effect of high energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 1992; 22:147-152.

79. Watkin NA, Morris SB, Rivens H, Ter Harr GR. High intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol 1997; 11:191-196.

80. Köhrmann KU, Michel MS, Steidler A, Marlinghaus E, Kraut O, Alken P. Technical characterizations of an ultrasound source for noninvasive thermoablation by high-intensity focused ultrasound. BJU Int 2002; 90:248-252.

81. Köhrmann KU, Michel MS, Gaa J, Marlinghaus E, Alken P. High intensity focused ultrasound as noninvasive therapy for multifocal renal cell carcinoma: case study and review of the literature. J Urol 2002; 167:2397-2403.

82. Susani M, Madersbacher S, Kratzik CH, Vingers L, Marberger M. Morphology of tissue destruction induced by focused ultrasound. Eur Urol 1993; 23:34-38.

83. Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high intensity focused ultrasound. Ultrasound Med Biol 2001; 27:1096-1106.

84. Wu F, Wang ZB, Chen WZ, et al. Extracorporeal high intensity focused ablation in the treatment of 1038 patients with solid carcinomas in Chine: an overview. Ultrason Sonochem 2004; 11:149-154.

85. Wu F, Wang ZB, Chen WZ, Bai J, Zhu H, Qiao TY. Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol 2003; 170:2237-2240.

86. Kennedy JE, Clarke RL, Ter Haar GR. The effects of absorbers such as ribs in the HIFUS beam-path on the focal profile. In: Andrew MA, Crum LA, Vaezys, eds. Proceedings, 2nd international symposium on therapeutic ultrasound. Seattle: University of Washington 2003:185-192.

87. Ter Haar G, Kennedy J, Wu F. HIFUS treatments: dosimetric considerations. In: Andrew MA, Crum LA, Vaezys, eds. Proceedings, 2nd international symposium on therapeutic ultrasound. Seattle: University of Washington 2003:307-313.

88. Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumors with high intensity focused ultrasound. Br J Urol 2005; 95:52-55.

89. Smith NB, Buchanan MT, Hynynen K. Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry. Int J Radiat Oncol Biol Phys 1999; 43:217-225.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment